This is consistent with recent studies reporting autophagy promotion upon cycloastragenol treatment through the AMPK/ULK1/mTOR pathway in human non-small-cell lung cancer lines [37] or via Notch1 signaling in human keratinocytes [51]. Here, MTOR is linked to non-small cell lung carcinoma.